Search results
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 3 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Earnings call: Teva Pharmaceuticals reports growth and pipeline progress By Investing.com
Investing.com· 3 days agoFinancial highlights include a 5% revenue increase, a 12% rise in adjusted EBITDA, and an 18%...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 4 days agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
Stocks making the biggest moves midday: Uber, Intel, Lyft, Shopify, Rivian and more
CNBC· 4 days agoThese are the stocks posting the largest moves in midday trading.
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 4 days agoHighly Rated Pharma Stock Meanwhile, sales of its generic drugs rose more than 6% globally to $2.29...
An Expert Talks About New Research on Migraine Treatments
Healthline· 3 days agoNeurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the...
Why Is Teva Pharmaceutical Stock Trading Higher On Wednesday? - Teva Pharmaceutical Indus...
Benzinga· 4 days agoWednesday, Teva Pharmaceutical Industries Ltd TEVA and Medincell announced results from the efficacy...
Teva stock gains on trial win, Q1 beat (NYSE:TEVA)
Seeking Alpha· 4 days agoTeva Pharmaceutical (TEVA) stock posts record gains due to better-than-expected Q1 revenue and positive Phase 3 trial results for its schizophrenia drug....
Teva Pharm Q1 profit misses estimates, revenue risea
WHTC 1450 Holland· 4 days agoBy Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales ...
Teva Pharma Gains on Q1 Revenue Beat
Investing.com· 5 days agoTeva Pharma Gains on Q1 Revenue Beat
